BIOMAT Database Logo BIOMAT Database Logo

Antibodies to hepatitic C virus and chronic liver disease among Finnish patients with haemophilia. 1990

F Ebeling, and V Rasi, and R Naukkarinen, and J Leikola
Finnish Red Cross Blood Transfusion Service, Helsinki, Finland.

Antibodies to hepatitis C virus, hepatitis B serology and liver enzymes were examined in 137 Finnish haemophiliac patients to detect signs of chronic viral hepatitis and its possible aetiological associations. The prevalence of raised alanine aminotransferase values was 37%. These were significantly associated with hepatitis C seropositivity but not with hepatitis B antibodies, severity of haemophilia or the type of clotting factor used in replacement therapy. The prevalence of hepatitis C seropositivity was 50%; it was significantly associated with severe haemophilia and with the use of large pool concentrates. The hepatitis C virus seems to be the major cause of chronic liver disease transmitted by clotting factors also in Finland, despite a somewhat lower seroprevalence than described elsewhere so far.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D005260 Female Females
D005387 Finland A country in northern Europe, bordering the Baltic Sea, Gulf of Bothnia, and Gulf of Finland, between Sweden and Russia. The capital is Helsinki. Aland Islands,Åland Islands
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic

Related Publications

F Ebeling, and V Rasi, and R Naukkarinen, and J Leikola
Prevalence of antibodies to hepatitis C virus among Turkish patients with chronic liver disease.
March 1993, Journal of internal medicine,
F Ebeling, and V Rasi, and R Naukkarinen, and J Leikola
Prevalence of antibodies to hepatitis C virus among Saudi patients with chronic liver diseases.
August 1992, Hepato-gastroenterology,
F Ebeling, and V Rasi, and R Naukkarinen, and J Leikola
Chronic liver disease and active hepatitis C virus infection in patients with antibodies to this virus.
February 1994, Journal of clinical pathology,
F Ebeling, and V Rasi, and R Naukkarinen, and J Leikola
Interferon antibodies in patients with chronic hepatitic C virus infection treated with recombinant interferon alpha-2 alpha.
March 1994, Journal of hepatology,
F Ebeling, and V Rasi, and R Naukkarinen, and J Leikola
Prevalence of antibodies to hepatitis C virus in Greek patients with chronic liver disease.
June 1994, Journal of hepatology,
F Ebeling, and V Rasi, and R Naukkarinen, and J Leikola
Prevalence of antibodies to hepatitis C virus in Greek patients with chronic liver disease.
February 1994, Journal of hepatology,
F Ebeling, and V Rasi, and R Naukkarinen, and J Leikola
Prevalence of antibodies to hepatitis C virus in Saudi patients with chronic liver disease.
September 1991, Annals of Saudi medicine,
F Ebeling, and V Rasi, and R Naukkarinen, and J Leikola
The prevalence of antibodies to hepatitis C virus in patients with chronic liver disease.
May 1992, The New Zealand medical journal,
F Ebeling, and V Rasi, and R Naukkarinen, and J Leikola
Antibodies to a putative hepatitis C virus polyprotein in Japanese patients with chronic liver disease.
October 1992, Journal of medical virology,
F Ebeling, and V Rasi, and R Naukkarinen, and J Leikola
Liver disease in dialysis patients with antibodies to hepatitis C virus.
November 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Copied contents to your clipboard!